Si-Bone (SIBN) Operating Income Growth (3y) (2020 - 2026)
Si-Bone (SIBN) Operating Income Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | 7.13% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | -2.70% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 75.54% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 34.83% |
| 10 | Si-Bone | 752.15 Mn | 607.47 Mn | 41.94 Mn | 23.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.31% |
| Dec 31, 2025 | 39.81% |
| Sep 30, 2025 | 26.52% |
| Jun 30, 2025 | 26.83% |
| Mar 31, 2025 | 23.74% |
| Dec 31, 2024 | 26.67% |
| Sep 30, 2024 | 16.69% |
| Jun 30, 2024 | 8.05% |
| Mar 31, 2024 | -1.33% |
| Dec 31, 2023 | -16.69% |
| Sep 30, 2023 | -8.79% |
| Jun 30, 2023 | -5.67% |
| Mar 31, 2023 | 1.68% |
| Dec 31, 2022 | -10.00% |
| Sep 30, 2022 | -8.64% |
| Jun 30, 2022 | -30.00% |
| Mar 31, 2022 | -24.23% |
| Dec 31, 2021 | -47.89% |
| Sep 30, 2021 | -63.07% |
| Jun 30, 2021 | -96.95% |